News – Archive

Grindeks: EU-funded Competence Centres Program is important to the development of Latvia’s national economy

JSC Grindeks informs that the Company takes part in two EU-funded competence centres – “Pharma and Chemistry Competence Centre” and “Environment, Bioenergetics and Biotechnology Competence...

07/02/2012

JSC Grindeks Foundation “For the Support of Science and Education” awards premiums to teachers, higher educational institutions` teaching staff and educational institutions

JSC Grindeks Foundation “For the Support of Science and Education” informs thatt oday, on 29 December, it has awarded teachers, higher educational institutions` teaching staff...

29/12/2011

JSC Grindeks original preparation Mildronate® GX recognised as “The Cardiological Medication of the Year” in Ukraine

The original preparation Mildronate® GX of Grindeks has received the prestigious award and nomination “The Cardiological Medication of the Year” in the awarding ceremony of...

03/10/2011

Grindeks will participate in the exhibition „CPhI Worldwide 2011”

From October 25 to 27, JSC Grindeks will participate in the international exhibition “CPhI Worldwide 2011” in Messe Frankfurt, Germany. During the exhibition Grindeks will...

21/09/2011

Grindeks invites media to opening ceremony of UDCA manufacturing unit on 16 June 2011

Active pharmaceutical ingredients UDCA* manufacturing unit is one of Grindeks most significant investment projects. The total contribution of the new manufacturing unit consists of 6.34...

13/06/2011

Grindeks vitamins return in packaging developed by students of Art Academy of Latvia

Grindeks informs that starting this autumn in Latvian pharmacies will once again be offered the company`s manufactured vitamins. Vitamin Gritamin® series will have six products...

10/06/2011

Representatives of European Commission, Latvian Investment and Development Agency and Latvian Finance Ministry visit JSC Grindeks

JSC Grindeks informs that today, on 29 March, the company is visited by the representatives of the European Commission, the Latvian Investment and Development Agency...

29/03/2011

Grindeks establishes new anti-cancer manufacturing unit

Joint-stock company Grindeks informs that it has established a new anti-cancer final dosage forms’ manufacturing unit, in which 400 thousand lats have been invested. Production...

04/02/2011

Grindeks successfully continues registration of Mildronate® in China

JSC Grindeks informs that the company successfully continues registration of Mildronate® in the People’s Republic of China. Last week in China, Beijing Grindeks management representatives...

27/01/2011